Assessment and treatment relevance in elderly glioblastoma patients
Authors:
- Luc BauchetLBLuc Bauchet
- Sonia ZouaouiSZSonia Zouaoui
- Amélie DarlixADAmélie Darlix
- Nicolas Menjot de ChampfleurNCNicolas Menjot de Champfleur
- Ernestine FerreiraEFErnestine Ferreira
- Michel FabbroMFMichel Fabbro
- Christine KerrCKChristine Kerr
- Luc TaillandierLTLuc Taillandier
Open Access
- 2 May 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 16 (11) , 1459-1468
Abstract
Glioblastoma (GBM) is the most common malignant primary brain tumor. Its incidence continues to increase in the elderly because the older segment of the population is growing faster than any other age group. Most clinical studies exclude elderly patients, and “standards of care” do not exist for GBM patients aged >70 years.Keywords
This publication has 87 references indexed in Scilit:
- Screening older cancer patients: first evaluation of the G-8 geriatric screening toolAnnals of Oncology, 2012
- Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomideJournal of Neuro-Oncology, 2010
- EORTC elderly task force position paper: Approach to the older cancer patientEuropean Journal of Cancer, 2010
- Radiation Dose–Volume Effects in the BrainInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Reirradiation Tolerance of the Human BrainInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987